peripheral blood withdrawal

PROCEDURE2 trials

Sponsors

Neuromed IRCCS

Conditions

HealthyNeuromyelitis OpticaPatient ParticipationRelapsing-Remitting Multiple Sclerosis (RRMS)

Unknown Phase

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

Neuromed IRCCSHealthy, Neuromyelitis Optica, Relapsing-Remitting Multiple Sclerosis (RRMS)

Start: 2022-04-01End: 2023-10-31Target: 154Updated: 2022-02-17

Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS

RecruitingNCT05779449

Neuromed IRCCSPatient Participation

Start: 2023-07-26End: 2026-05-01Target: 100Updated: 2023-08-14